Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Liabilities and Shareholders Equity (2016 - 2025)

Dexcom (DXCM) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $6.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 2.23% to $6.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $20.4 billion, a 214.88% increase, with the full-year FY2025 number at $6.3 billion, down 2.23% from a year prior.
  • Liabilities and Shareholders Equity was $6.3 billion for Q4 2025 at Dexcom, down from $7.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $7.3 billion in Q2 2025 to a low of $4.4 billion in Q1 2021.
  • A 5-year average of $5.8 billion and a median of $6.3 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 79.33% in 2021, then decreased 2.23% in 2025.
  • Dexcom's Liabilities and Shareholders Equity stood at $4.9 billion in 2021, then rose by 9.29% to $5.4 billion in 2022, then rose by 16.19% to $6.3 billion in 2023, then rose by 3.51% to $6.5 billion in 2024, then dropped by 2.23% to $6.3 billion in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Liabilities and Shareholders Equity are $6.3 billion (Q4 2025), $7.3 billion (Q2 2025), and $6.8 billion (Q1 2025).